133 related articles for article (PubMed ID: 33516374)
21. Laser ablation ICP-MS for simultaneous quantitative imaging of iron and ferroportin in hippocampus of human brain tissues with Alzheimer's disease.
Cruz-Alonso M; Fernandez B; Navarro A; Junceda S; Astudillo A; Pereiro R
Talanta; 2019 May; 197():413-421. PubMed ID: 30771955
[TBL] [Abstract][Full Text] [Related]
22. Interface engineering of microelectrodes toward ultrasensitive monitoring of β-amyloid peptides in cerebrospinal fluid in Alzheimer's disease.
Ding S; Xu Y; Liu Q; Gu H; Zhu A; Shi G
Analyst; 2020 Mar; 145(6):2331-2338. PubMed ID: 32030384
[TBL] [Abstract][Full Text] [Related]
23. Robust and Universal SERS Sensing Platform for Multiplexed Detection of Alzheimer's Disease Core Biomarkers Using PAapt-AuNPs Conjugates.
Zhang X; Liu S; Song X; Wang H; Wang J; Wang Y; Huang J; Yu J
ACS Sens; 2019 Aug; 4(8):2140-2149. PubMed ID: 31353891
[TBL] [Abstract][Full Text] [Related]
24. Effects of Gold Nanospheres and Nanocubes on Amyloid-β Peptide Fibrillation.
Wang W; Han Y; Fan Y; Wang Y
Langmuir; 2019 Feb; 35(6):2334-2342. PubMed ID: 30636427
[TBL] [Abstract][Full Text] [Related]
25. Gelsolin bound β-amyloid peptides(1-40/1-42): electrochemical evaluation of levels of soluble peptide associated with Alzheimer's disease.
Yu Y; Sun X; Tang D; Li C; Zhang L; Nie D; Yin X; Shi G
Biosens Bioelectron; 2015 Jun; 68():115-121. PubMed ID: 25562737
[TBL] [Abstract][Full Text] [Related]
26. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
Watanabe H
Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
[TBL] [Abstract][Full Text] [Related]
27. Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid β-Protein Aggregation and Cytotoxicity.
Xiong N; Zhao Y; Dong X; Zheng J; Sun Y
Small; 2017 Apr; 13(13):. PubMed ID: 28112856
[TBL] [Abstract][Full Text] [Related]
28. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
[TBL] [Abstract][Full Text] [Related]
29. A novel absolute quantitative imaging strategy of iron, copper and zinc in brain tissues by Isotope Dilution Laser Ablation ICP-MS.
Feng L; Wang J; Li H; Luo X; Li J
Anal Chim Acta; 2017 Sep; 984():66-75. PubMed ID: 28843570
[TBL] [Abstract][Full Text] [Related]
30. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564
[TBL] [Abstract][Full Text] [Related]
31. The Clustering of mApoE Anti-Amyloidogenic Peptide on Nanoparticle Surface Does Not Alter Its Performance in Controlling Beta-Amyloid Aggregation.
Corti R; Cox A; Cassina V; Nardo L; Salerno D; Marrano CA; Missana N; Andreozzi P; Silva PJ; Stellacci F; Dal Magro R; Re F; Mantegazza F
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033502
[TBL] [Abstract][Full Text] [Related]
32. How Do the Size, Charge and Shape of Nanoparticles Affect Amyloid β Aggregation on Brain Lipid Bilayer?
Kim Y; Park JH; Lee H; Nam JM
Sci Rep; 2016 Jan; 6():19548. PubMed ID: 26782664
[TBL] [Abstract][Full Text] [Related]
33. Label-free detection of ApoE4-mediated β-amyloid aggregation on single nanoparticle uncovering Alzheimer's disease.
Kang MK; Lee J; Nguyen AH; Sim SJ
Biosens Bioelectron; 2015 Oct; 72():197-204. PubMed ID: 25982728
[TBL] [Abstract][Full Text] [Related]
34. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
Chatterjee P; Elmi M; Goozee K; Shah T; Sohrabi HR; Dias CB; Pedrini S; Shen K; Asih PR; Dave P; Taddei K; Vanderstichele H; Zetterberg H; Blennow K; Martins RN
J Alzheimers Dis; 2019; 71(3):775-783. PubMed ID: 31424403
[TBL] [Abstract][Full Text] [Related]
35. Anti-Aβ drug candidates in clinical trials and plasmonic nanoparticle-based drug-screen for Alzheimer's disease.
Lee D; Lee G; Yoon DS
Analyst; 2018 May; 143(10):2204-2212. PubMed ID: 29632940
[TBL] [Abstract][Full Text] [Related]
36. Visual and fluorescent assays for selective detection of beta-amyloid oligomers based on the inner filter effect of gold nanoparticles on the fluorescence of CdTe quantum dots.
Xia N; Zhou B; Huang N; Jiang M; Zhang J; Liu L
Biosens Bioelectron; 2016 Nov; 85():625-632. PubMed ID: 27240009
[TBL] [Abstract][Full Text] [Related]
37. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
[TBL] [Abstract][Full Text] [Related]
38. Quantitative MRI and laser ablation-inductively coupled plasma-mass spectrometry imaging of iron in the frontal cortex of healthy controls and Alzheimer's disease patients.
Bulk M; Abdelmoula WM; Geut H; Wiarda W; Ronen I; Dijkstra J; van der Weerd L
Neuroimage; 2020 Jul; 215():116808. PubMed ID: 32289451
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.
Maiti P; Hall TC; Paladugu L; Kolli N; Learman C; Rossignol J; Dunbar GL
Histochem Cell Biol; 2016 Nov; 146(5):609-625. PubMed ID: 27406082
[TBL] [Abstract][Full Text] [Related]
40. Naked-eye detection of amyloid aggregates using gold nanoparticles modified with amyloid beta antibody.
Sakono M; Zako T; Maeda M
Anal Sci; 2012; 28(1):73. PubMed ID: 22232229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
